DDDirk Wilhelm Donker

Dirk Wilhelm Donker

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dirk Wilhelm Donker has a total of 501 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Time-Dependent Effects of Inotropic Exposure During Venoarterial Extracorporeal Membrane Oxygenation Support on the Probability of Extracorporeal Membrane Oxygenation Weaning Failure

    by Myrthe P.J. van Steenwijk, Lara C.A. Pladet, Atreyu van Esch, Hong Jun Shi, Dirk W. Donker, Yannick Taverne, Jeroen J.H. Bunge, Carlos V. Elzo Kraemer, Jacinta J. Maas, Leon J. Montenij, et al.

    OBJECTIVES: During venoarterial extracorporeal membrane oxygenation (VA ECMO), organ perfusion no longer entirely depends on native cardiac output, which may reduce the therapeutic advantage of inotropic drugs relative to their risks. We hypothesized that, in this setting, higher cumulative inotropic exposure would be associated with impaired cardiac recovery. DESIGN: Observational cohort study on the effects of longitudinal inotropic exposure during VA ECMO support. Temporal changes in inotropic support during VA ECMO support were evaluated. Cumulative inotropic exposure per day during VA ECMO support was calculated using the area under the curve of a standardized inotropic score. These cumulative inotropic scores were associated with the risk of ECMO weaning failure up to 30 days (a composite of death, ongoing need for ECMO support, or the need for heart replacement therapy), mortality, and complications, using joint modeling techniques. SETTING: Six hospitals in the Netherlands. PATIENTS: Adult patients with severe cardiogenic shock (CS) receiving VA ECMO support between 2018 and 2024. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Out of 440 patients with various causes of CS, 235 patients (53.4%) developed ECMO weaning failure. Inotropic support remained largely unchanged in the days following VA ECMO initiation. Adjusted joint models showed that a higher cumulative inotropic exposure during VA ECMO support was associated with an increased risk for ECMO weaning failure (hazard ratio [HR], 1.04; 95% CI, 1.00–1.07), 30-day mortality (HR, 1.04; 95% CI, 1.01–1.08), arrhythmias (HR, 1.05; 95% CI, 1.01–1.08), and protracted lactate clearance (HR, 0.96; 95% CI, 0.92–0.99). CONCLUSIONS: In patients requiring VA ECMO support for refractory CS, inotropic support is often maintained at similar levels after ECMO initiation. Higher cumulative inotropic exposure was associated with an increased risk for ECMO weaning failure. Prospective studies are needed to investigate whether inotropes can be tapered or even stopped and whether such a strategy could improve cardiac recovery.


  • Open Access

    In-silico credibility assessment of a computational physiological model for non-invasive monitoring of respiratory effort in critically ill patients

    by R S P Warnaar, S Geraats, A D Cornet, R G K M Aarts, J Graßhoff, D W Donker, E Oppersma

    Objective. Monitoring respiratory effort in critically ill patients during assisted mechanical ventilation is essential to individualize ventilatory support and prevent over- or underassistance. A non-invasive method to estimate respiratory muscle pressure ( P mus ) combines respiratory surface electromyography (sEMG) with ventilator pressure-flow waveforms through the integrated equation of motion (iEqM). Implemented within a computational physiological model (CPM), the iEqM links muscle activation to generated pressure. This study investigates the reliability of an iEqM-based CPM under critical care conditions. Approach. CPM performance to estimate respiratory muscle pressure-time product ( P T P ^ mus ) was evaluated in-silico using simulated patient profiles. Credibility activities included numerical verification, Monte-Carlo-based uncertainty quantification, and sensitivity analysis, exploring variations in respiratory mechanics, effort variability, sEMG signal quality, and patient-ventilator timing. Model outputs were compared with simulated reference values, with an acceptable clinical error margin set at 20%. Main results. Verification confirmed correct model implementation (errors < 0.3%). Input data uncertainty quantification showed limited variability (SD 1.8%). Sensitivity analysis revealed reduced accuracy under low P mus variability (< 5.0 cmH 2 O), low sEMG signal-to-noise ratios ( S N R ^ < 1.4), high P mus magnitudes (17.5 cmH 2 O), and persistent inspiratory efforts during expiration. Calibration using end-expiratory occlusion maneuvers improved accuracy, except at the lowest P mus magnitude and S N R ^ s. Significance. The iEqM performs reliably when calibrated via end-expiratory occlusion maneuvers. Without calibration, accuracy declined with lower effort variability, poorer sEMG quality, or patient-ventilator asynchrony. These findings emphasize the need for context-aware application, accounting for patient-specific mechanics, signal integrity and ventilator interaction, to ensure credible and reliable monitoring of respiratory effort in critically ill patients.

  • Open Access

    Hypotension Prediction Index versus Mean Arterial Pressure Alarm for Preventing Intraoperative Hypotension in Elective Noncardiac Surgery: A Randomized Controlled Trial

    by Anna A. Florax, Marijn P. Mulder, Roland P. van Ieperen, Libera Fresiello, Dirk W. Donker, Jan-Willem Potters

    Background: Intraoperative hypotension is common during surgery and has been retrospectively associated with acute kidney injury, myocardial injury, and increased mortality. The Hypotension Prediction Index was developed to support proactive blood pressure management but shows a strong correlation with mean arterial pressure. Observational data suggest that a mean arterial pressure alarm set at 72 mmHg may perform similarly to the default Hypotension Prediction Index alarm (greater than 85). The authors hypothesized that a 72 mmHg mean arterial pressure alarm is noninferior to the Hypotension Prediction Index in preventing intraoperative hypotension. Methods: In this single-center, blinded, randomized controlled trial, adults undergoing moderate- or high-risk elective noncardiac surgery with continuous arterial pressure monitoring were assigned to either a mean arterial pressure alarm (less than 72 mmHg) or a Hypotension Prediction Index alarm (greater than 85). The primary outcome was the area under the threshold for mean arterial pressure less than 65 mmHg. Secondary outcomes included the incidence and severity of hypo- and hypertension, duration of active alarms, incidence of acute kidney and myocardial injury, 30-day mortality, hospital length of stay, and cumulative dosages of vasoactive medication and fluids. Results: A total of 143 participants were included in the final analysis. The median [IQR] area under the hypotension threshold was 3.75 [0.00 to 22.62] mmHg ⋅ min in the mean arterial pressure group and 4.00 [0.00 to 19.00] mmHg ⋅ min in the Hypotension Prediction Index group. After log-transformation, the mean difference was 0.03 (95% CI, −0.24 to 0.29), with the lower bound remaining above the predefined noninferiority margin (−0.4). No differences were observed in secondary hemodynamic metrics, alarm characteristics, patient outcomes, or administered medications and fluids. Conclusion: A mean arterial pressure alarm of 72 mmHg is noninferior to the Hypotension Prediction Index greater than 85 in preventing intraoperative hypotension. Given its simplicity and broad availability, a mean arterial pressure alarm of 72 mmHg represents a pragmatic and cost-effective alternative for proactive blood pressure management.


  • Acute Right Ventricular Failure in Animal Models: Evidence, Limitations, and Future Directions

    by Paolo Manca, Vincenzo Nuzzi, Antonella Peccianti, Lisa Prahl Wittberg, Maximilian Valentin Malfertheiner, Lars Mikael Broman, Mirko Belliato, Johannes Heinze, Lorenzo Grazioli, Matthias Raes, et al.

    Acute right ventricular failure (ARVF) is a life‐threatening condition commonly encountered in the intensive care unit. The treatment of ARVF profoundly changed in the last years, with a growing number of mechanical circulatory support (MCS) devices that have been deployed in clinical practice to support patients with severe forms of ARVF. However, comparative clinical data addressing the superiority of the different MCS strategies are lacking. Several animal models addressing ARVF have been proposed in the literature, and they have been crucial to increase the knowledge on right ventricular (RV) pathophysiology and response to different stressors. Nevertheless, models that reliably mimic acute RV severe failure, ventricular–pulmonary artery uncoupling, and cardiogenic shock are comparatively scarce. Furthermore, only a limited number of experimental studies have incorporated MCS devices in this setting, and direct head‐to‐head comparisons between different support strategies are largely lacking. This gap in preclinical experiences significantly limits the development of evidence‐based algorithms for right‐sided MCS deployment. In this review, we summarize currently available animal models of ARVF, critically highlighting their methodological strengths and limitations, and examining the evidence supporting the use of MCS within these frameworks. By highlighting the translational limitations of the existing preclinical experiences, we underscore the urgent need for standardized, reproducible, and clinically relevant ARVF models. Such efforts are essential to improve the current treatment of ARVF, and they could be particularly relevant in developing and optimizing MCS devices and their selection, ultimately enhancing outcomes in patients with ARVF.

  • Open Access

    PMB-NN: Physiology-centered hybrid AI for personalized hemodynamic monitoring from photoplethysmography

    by Yaowen Zhang, Libera Fresiello, Peter H. Veltink, Dirk W. Donker, Ying Wang

  • Spoilt for choice? Temporary mechanical circulatory support in cardiogenic shock: The importance of the patient

    by Dirk W. Donker, Libera Fresiello

    Despite major advances in temporary mechanical circulatory support (tMCS), cardiogenic shock remains associated with high mortality. Early management strategies were dominated by the intra-aortic balloon pump (IABP), widely adopted on physiological grounds despite limited randomized evidence and later declining use due to downgraded guideline recommendations. Subsequent shifts toward more potent tMCS devices, including transaortic micro-axial flow pumps and venoarterial extracorporeal membrane oxygenation (VA ECMO), were driven by the pursuit of improving systemic perfusion and ventricular unloading. However, enhanced hemodynamic support has not consistently translated into superior clinical outcomes and is frequently accompanied by substantial device-related complications. Increasing recognition of the complex and patient-specific physiology of cardiogenic shock has fueled a transition from device-centred to patient-centred strategies, emphasizing tailored support configurations, multimodal monitoring, and physiology-driven decision-making. Adjunct left ventricular unloading during VA ECMO has emerged as a promising yet controversial approach, with ongoing trials expected to clarify its clinical role. Recent evidence, including the DanGer Shock trial, suggests that timely initiation of appropriately selected tMCS may improve longer-term outcomes in selected populations. Parallel advances in biomedical engineering have enabled physiology-based cardiovascular simulators that allow systematic comparison of tMCS strategies, pharmacological support, and device hemocompatibility under controlled conditions. When extended to virtual populations, these in silico approaches can complement clinical evidence through virtual clinical trials, potentially reducing the size and cost of traditional studies. Together, these developments highlight a new era of patient-centred critical care and biomedical innovation in cardiogenic shock.

  • Open Access

    Guiding complexity in V-A ECMO weaning decisions for cardiogenic shock: Insights from a conjoint analysis

    by J. A. J. Hermens, J. A. Van Til, L. Van Loon, N. A. Barrett, J. Swol, R. Lorusso, D. Van Dijk, C. L. Meuwese, D. W. Donker

    Weaning and liberation from V-A ECMO for cardiogenic shock involves complex decision-making that requires balancing multiple clinical parameters. In the absence of specific weaning guidelines, ECMO centers rely on heterogeneous, institution-specific practices, which may adversely affect outcome. To gain insights into how professionals weigh multiple factors in complex weaning decisions, a survey was designed using conjoint analysis. The survey was presented to a large cohort of international ECMO clinicians via the EuroELSO network online between February 16, 2024 and May 1, 2024. Using conjoint analysis, a set of 14 hypothetical adult weaning scenarios, incorporating combinations of different attributes with varying levels across 4 cardiogenic shock etiologies was presented. Participants had to decide on liberation from ECMO (‘yes’ or ‘no’) based on a personal trade-off weighing all presented attributes for each scenario. In total, 316 participants from 49 different countries evaluated 4424 hypothetical scenarios. Pulse Pressure ≥30 mmHg (OR 2.56 (CI 2.03–3.24), cardiac index >2.1 L/min/m² (OR 2.5 (CI 1.87–3.43) and echocardiographically assessed left ventricular outflow velocity time integral (VTI) >15 cm (OR 2.53 (95% CI 201-3.2) all favored positive weaning decisions (all p < 0.001). Vasoactive-inotropic score (VIS; 11.1%), VTI (9.7%) and the presence of peripheral and/or pulmonary edema (9.8%) had the highest relative importance to overall weaning decisions. Echocardiography was found to contribute more to weaning decisions in ECMO novices. Weaning decisions were predominantly driven by parameters reflecting cardiac recovery. Leveraging these insights may set the stage for a clinical decision-support tool to benchmark individual practice against expert consensus.


  • Open Access

    Mechanistic Insights into Skin Sympathetic Nerve Activity Dynamics in Healthy Subjects Through a Two-Layer Signal-Analytical and Closed-Loop Physiological Modeling Framework

    by Runwei Lin, Frank R. Halfwerk, Dirk W. Donker, Jacomine Tertoolen, Vincent R. van der Pas, Gozewijn Dirk Laverman, Ying Wang

    Objective: Skin sympathetic nerve activity (SKNA) has emerged as a promising non-invasive surrogate measure of sympathetic drive, but its relevant physiological characteristics remain ill-defined. This observational study aims to investigate its regulatory patterns during rest and Valsalva maneuver (VM) in healthy participants. Method: Using a two-layer strategy integrating signal analysis and physiological modelling, we analyzed data recorded from 41 subjects performing repeated VMs. The observational layer includes time-domain feature comparisons using linear mixed-effect models, and time-varying spectral coherence analysis. The mechanistic layer proposes a mathematical model to investigate whether baroreflex and respiratory modulation are sufficient to reproduce the observed HR and average SKNA (aSKNA) dynamics. Main Results: Mean integrated SKNA (iSKNA) showed more significant change than HRV for VM induced effects. We also found mean iSKNA increase during VM varies with BMI and sex. The coherence analysis indicated that iSKNA strongly synchronized with EDR under resting conditions. The proposed model successfully reproduced main characteristics of aSKNA dynamics, yielding a high median Pearson correlation coefficient of 0.80 ([Q1, Q3] = [0.60, 0.91]). In contrast, HR dynamics were only partially captured, with a median PCC of 0.37 ([Q1, Q3] = [0.16, 0.55]). These results likely suggest SKNA provides a more direct representation of sympathetic burst dynamics during VM in healthy subjects. Significance: This study provides convergent evidence that SKNA reflects known autonomic regulatory influences in healthy subjects. These findings strengthen the physiological interpretability of SKNA while clarifying its appropriate use as a practical biomarker of sympathetic function.

  • Open Access

    Exploring weaning-related shock: Cardiac injury and overload, platelet-endothelial cell activation, and inflammatory response markers following ECMO decannulation

    by Lara C.A. Pladet, Carlos V. Elzo Kraemer, Stefan Nierkens, Jeannine A. Hermens, Emma Rademaker, Lennie P.G. Derde, Christiaan L. Meuwese, Dirk W. Donker, Olaf L. Cremer

    Introduction: Mortality in patients receiving Extracorporeal Membrane Oxygenation (ECMO) is partly attributable to unanticipated hemodynamic instability after elective decannulation, termed weaning-related shock (WRS). This study explored the etiology of WRS by analyzing sequential plasma biomarker profiles. Methods: We analyzed a prospective cohort (2011–2022) of consecutive patients weaned from veno-arterial (V-A) or veno-venous (V-V) ECMO to evaluate WRS occurrence. WRS was defined as a rise in Vasoactive Inotropic Score ≥15 points for >6 h with a positive fluid balance and lactate >2 mmol/L within 72 h post-decannulation. Shock etiology was adjudicated as hemorrhagic, cardiogenic, septic, or unclassifiable. Subsequently, key plasma biomarkers reflecting inflammation, platelet-endothelial cell activation, and cardiac injury and overload were assessed pre- and post-decannulation, stratified on WRS occurrence, apparent etiology, and ECMO mode. Results: Out of 97 eligible individuals, 88 (91%) were analyzed (70 V-A and 18 V-V). Among them, 24 (27%) patients developed WRS, all of whom had received V-A ECMO. WRS was attributed to hemorrhagic, cardiogenic, septic, or unclassifiable causes in 0, 8, 8 and 8 cases, respectively. No differences were observed between groups in markers of inflammation or platelet-endothelial cell activation, nor in their trajectories over time. Conversely, NT-proBNP levels, but not HsTnI, increased significantly after decannulation in WRS patients compared to V-V or V-A ECMO patients without WRS ( p = 0.003 and p = 0.02, respectively). NT-proBNP was also higher in these subjects prior to decannulation (all p < 0.001). Conclusion: Biomarker responses following ECMO decannulation suggest cardiac overload as the primary driver of WRS, irrespective of clinical shock diagnosis.